Status:

WITHDRAWN

Macrolane Prospective Survey

Lead Sponsor:

Galderma R&D

Collaborating Sponsors:

Pharma Consulting Group AB

Conditions:

Females Recently Treated With Macrolane VRF in the Breasts

Eligibility:

FEMALE

Brief Summary

The study objective is to evaluate the long term safety when Macrolane Volume Restoration Factor is used in female breasts in clinical practice.

Eligibility Criteria

Inclusion

  • Females recently treated with Macrolane Volume Restoration Factor in the breasts.
  • Signed informed consent

Exclusion

  • There are no exclusion criteria

Key Trial Info

Start Date :

September 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2010

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01223066

Start Date

September 1 2010

End Date

October 1 2010

Last Update

August 25 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Akademikliniken

Stockholm, Sweden, 115 42